-
View DetailPROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Feb 2025 -
View Detail
PROTAPHANE PENFILL human insulin (rys) 100IU/mL injection multidose cartridge
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2026 -
View Detail
LEVEMIR PENFILL insulin detemir (rys) 100 U/mL injection cartridge
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2026 -
View Detail
LEVEMIR FLEXPEN insulin detemir (rys) 100 U/mL injection cartridge
Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2026 -
CISATRACURIUM ACCORD cisatracurium (as besilate) 150 mg
Availability: Unavailable Deletion from market: 19 Sep 2024 -
View Detail
FIASP insulin aspart (rys) 100 units/mL solution for injection 10 mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024 -
View Detail
FIASP FLEXTOUCH insulin aspart (rys) 100 units/mL solution for injection 3 mL
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Mar 2025 -
View Detail
RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Feb 2025 -
Levophed 1:1000 noradrenaline (norepinephrine) 4mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024 -
CIPLA LENALIDOMIDE lenalidomide 5 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024 -
CIPLA LENALIDOMIDE lenalidomide 10 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024 -
CIPLA LENALIDOMIDE lenalidomide 15 mg
Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024